CLASS II ONGOING Device recall · Reported 12 Jun 2024 · FDA Enforcement Report

Arial mobile application recalled by Securitas Healthcare

Securitas Healthcare is recalling Arial mobile application, distributed nationwide in the US. The recall was initiated on 11 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesArial Mobile v11.0.0 UDI: (01)00840948100963(10)1100.
Quantity recalled661 sites with mobile application user licenses

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1943-2024
FDA event ID
94607
Recalling firm
Securitas Healthcare, Lincoln, NE
Classification
Class II
Status
Ongoing
Recall initiated
11 Apr 2024
FDA classified
31 May 2024
Reported
12 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction

Timeline

11 Apr 2024Recall initiated by company
31 May 2024Classified by FDA+50 days
12 Jun 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Arial Mobile Application utilizing Apple iOS 17.4 and iOS 17.5 is frequently restarting causing the app to receive alerts for all pending alarm notifications and other events when the app restarts, experience difficulty in placing and maintaining staff-to-staff phone calls, and frequently appears offline while the app restarts.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Arial mobile application, model numbers 54640, 54630, and 54630-SMA, that utilizes Apple iOS 17.4 and Apple iOS 17.5, a component of the Arial Emergency and Nurse Call System.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Canada, England, Hong Kong, France, Qatar, and Spain.

Nationwide

Questions about this recall

Why was it recalled?

The Arial Mobile Application utilizing Apple iOS 17.4 and iOS 17.5 is frequently restarting causing the app to receive alerts for all pending alarm notifications and other events when the app restarts, experience difficulty in placing and maintaining staff-to-staff phone calls, and frequently appears offline while the app restarts.

Which lots are affected?

Arial Mobile v11.0.0 UDI: (01)00840948100963(10)1100.

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Canada, England, Hong Kong, France, Qatar, and Spain.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Securitas Healthcare

All 9

Other Other Medical Devices recalls

All 13,908